Navigation Links
Amicus Therapeutics Announces First Quarter 2008 Financial Results
Date:5/13/2008

.

Other Chaperone Programs:

Amicus is accelerating its investment in research and development to assess the potential for using pharmacological chaperones to treat a broader range of human genetic diseases beyond lysosomal storage diseases. As part of this effort, Amicus continues to conduct preclinical studies in Parkinson's disease, funded in part by a grant from the Michael J. Fox Foundation. In addition to the work in Parkinson's, Amicus is investing in new research aimed at evaluating disease targets for other neurodegenerative disorders and metabolic disorders.

Shire Collaboration:

In November 2007, Amicus entered into a strategic collaboration with Shire Human Genetic Therapies (HGT), a business unit of Shire plc, to jointly develop Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. In this collaboration valued at up to $440 million including an up front payment and success based clinical and sales milestones and excluding royalties and cost sharing, Shire also reimburses worldwide development costs on a 50/50 basis. Under the agreement, Shire received rights to commercialize these products outside of the United States. Amicus retains all rights to commercialize these products in the United States. Amicus will lead development operations through the end of Phase 2 clinical trials. The companies will then share responsibility for Phase 3 clinical trial development leveraging Shire's significant ex-US regulatory and clinical experience as well as its commercial infrastructure.

Additional Financial Results & Notes

On a reported basis, the net loss attributable to common stockholders for the three months ended March 31, 2008, was $7.7 million as compared to $9.7 million for the same period in 2007. On a non-GAAP basis, the net loss for the three months ended March 31, 2008, was $6.4 million as compared to $8.9 million and the same period in 2007.

Amic
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015 Tauriga Sciences, Inc. ... company with interests in the natural wellness sector and ... today that its products will be featured at the ... Partners, 27 th Annual Growth Stock Conference on ... at 1 Ritz Carlton Drive, Dana Point ...
(Date:2/26/2015)... 2015 CytomX, a biotechnology company developing Probody™ ... Sean McCarthy , D. Phil., chief executive officer, ... and Company 35 th Annual Health Care Conference ... will take place at 4 p.m. EST on Monday, ... Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...
(Date:2/25/2015)... , Feb. 25, 2015 /CNW/ - Radient Technologies Inc. (TSX-V: ... its financial results for the third quarter of its ... statements, Management,s Discussion and Analysis, and the CEO & ... ended December 31, 2014 are available on ... CFO Appointment The Corporation is also pleased to announce ...
(Date:2/25/2015)... Market Publishers Ltd is happy to ... 9Dimen Research have been recently uploaded to its catalogue. ... Research Report . This research report provides wealth of ... world adhesive mortar industry as well as includes an ... regional markets. It focuses on the main regions such ...
Breaking Biology Technology:SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 4
... Feb. 8 PharmAthene, Inc., a,biodefense company ... announced today that it has appointed Joan ... Dr. Fusco brings more than twenty years ... with broad experience in a variety of,functional ...
... in Spanish . , ANN ARBOR, Mich.---A ... walking to operate a portable GPS locator, a cell ... research involving the University of Michigan shows. , A ... 8 issue of the journal Science. Authors include researchers ...
... LifeCell Corporation,(Nasdaq: LIFC ), today announced revised preliminary ... final settlement of a claim that arose in,2007. The ... reduce,diluted net income per share by approximately $0.03. "Although ... the Company,s 2007,financial statements were not yet filed with ...
Cached Biology Technology:PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 2PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 3Knee brace generates electricity from walking 2LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern 2
(Date:2/5/2015)... New Market Research Reports Title ... To 2020 has Been Added to GrandViewReseach.com Report Database ... to reach USD 5.10 billion by 2020, according to ... cameras help identify the site of tissue damage in ... demand in medical imaging applications. They have been extensively ...
(Date:1/22/2015)... Jan. 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ... A Global Market Overview" report to their offering. ... to ensure that an individual is who she/he is claiming ... use of a person,s unique physical characteristics, such as fingerprint, ...
(Date:1/22/2015)...  BellBrook Labs, a leader in high throughput screening ... a TR-FRET (time resolved Forster resonance energy transfer) ... high throughput screening assay for glycosyltransferases and other ... sensitive detection of hundreds of human and microbial ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... who are overweight or obese can encounter a host of ... their children grow and develop, at least initially. In ... , a team led by a University of Iowa researcher ... and obese mothers with those born to normal-weight mothers. ...
... are in everything from ocean currents to a flower,s petal. ... studying the biodiversity of yard plants in the U.S. and ... bees live on the Tibetan plateau and how willow trees ... that ecology, the study of relationships between living organisms and ...
... (ICSSR) in association with the Deutsche For-schungsgemeinschaft (DFG, ... la Recherche (ANR), the UKEconomic and Social Research ... (NWO) have launched the first set of projects ... researchers in India and the four European countries. ...
Cached Biology News:Infants of overweight mothers grow more slowly 2Infants of overweight mothers grow more slowly 3Tale of 2 scientific fields -- ecology and phylogenetics -- offers new views of Earth's biodiversity 2Tale of 2 scientific fields -- ecology and phylogenetics -- offers new views of Earth's biodiversity 3First Indian-European research networking projects in the social sciences launched 2First Indian-European research networking projects in the social sciences launched 3First Indian-European research networking projects in the social sciences launched 4
... Tfi DNA Ligase catalyzes the formation ... and 5-phosphate termini in nicked duplex DNA ... duplex with a complementary strand at 45 ... and active at much higher temperatures than ...
RABBIT ANTI RHEB (IN) Immunogen: A 15 amino acid peptide located in the central region of human Rheb....
Rabbit polyclonal antibody to Neuromedin U Receptor 1 (GPR66)...
... sheer in-house demand is causing shortages in your ... This can cause unwanted distractions, problems and delays. ... your hard work and endeavour! Bring us your ... market it internationally. We work under ISO 9001 ...
Biology Products: